IL4 and breast carcinoma: As shown in Figure 4, the addition of Compound C to metformin-treated breast cancer cells significantly increased the expressions of IL-4, IL-10 and IL-13 when compared to metformin treatment alone (Figure 4D, 4E and 4F).